Home » Topics » BioWorld Science

BioWorld Science
RSS

Potential target identified for leukemia treatment

Sep. 10, 2019

New P300/CBP HAT inhibitors identified at Constellation Pharmaceuticals

Sep. 10, 2019

Dana-Farber Cancer Institute describes new IRAK degraders

Sep. 10, 2019

Newave Pharmaceutical presents Bruton tyrosine kinase inhibitors

Sep. 10, 2019

Vertex Pharmaceuticals patents CFTR modulators

Sep. 10, 2019

New TRPC6 antagonists identified at Boehringer Ingelheim

Sep. 10, 2019

RINT1 biallelic variants linked to recurrent acute liver failure and skeletal anomalies

Sep. 10, 2019

PCYT2 as a novel disease gene for complex hereditary spastic paraplegia

Sep. 10, 2019

Preclinical characterization of novel mGlu2 receptor PAMs for the treatment of substance abuse

Sep. 10, 2019

Cassava Sciences announces phase IIa data for PTI-125 in Alzheimer's disease

Sep. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...